Evidence map›Paper›PMID 38654201›Full record

ArticleBMC primary care2024

Primary Technology Enhanced Care Home HbA1c Testing (PTEC HAT) programme: a feasibility pilot study in Singapore.

Shilpa Tyagi, Gerald Choon-Huat Koh, Eng Sing Lee, Kah Pieng Ong, Roy Heng, Lian Hwa Er, Evonne Oh, Valerie Teo, David Wei Liang Ng

Open access · goldAbstract read
In one paragraph

Article in BMC primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shilpa TyagiMOH Office for Healthcare Transformation (MOHT), Singapore, Singapore.
Gerald Choon-Huat KohMOH Office for Healthcare Transformation (MOHT), Singapore, Singapore. Gerald.koh@moht.com.sg.
Eng Sing LeeMOH Office for Healthcare Transformation (MOHT), Singapore, Singapore.
Kah Pieng OngNational Healthcare Group Polyclinics, Singapore, Singapore.
Roy HengNational Healthcare Group Polyclinics, Singapore, Singapore.
Lian Hwa ErNational Healthcare Group Polyclinics, Singapore, Singapore.
Evonne OhNational Healthcare Group Polyclinics, Singapore, Singapore.
Valerie TeoNational Healthcare Group Polyclinics, Singapore, Singapore.
David Wei Liang NgNational Healthcare Group Polyclinics, Singapore, Singapore.
SingHealth Polyclinics · SGMOH Holdings · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConsidering time-consuming, cost-related limitations of laboratory-based HbA1c testing and follow-up clinic visits for diabetes management, it is important to explore alternative care models which incorporate point-of-care testing for HbA1c to monitor glycaemic control and related management.

methodsTherefore, we adopted an implementation perspective to conduct one group pre- and post-intervention feasibility pilot assessing feasibility, acceptability and satisfaction with conducting home HbA1c test by patients with type 2 diabetes coupled with telemonitoring and teleconsultations (i.e., the Primary Technology Enhanced Care (PTEC) Home HbA1c Testing (HAT) Programme) in Singaporean primary care setting. The secondary objective was to compare the HbA1c, blood pressure and primary care visits at the end or during intervention, vs. 6 months before. Adult patients with type 2 diabetes with HbA1c ≤ 8% without any diabetes complications and having phone compatibility were recruited. Data was collected via patient self-reports and electronic medical records extraction. While summary statistics and paired t-test were computed for quantitative data, open-ended feedback was analysed using content analysis.

resultsA total of 33 participants completed the intervention out of 37 (33/37 = 89%) recruited from 73 eligible (37/73 = 51%). Most were either 51 to 60 years old (46.9%) or more than 60 years (37.5%), with more males (53.1%) and majority Chinese (93.8%). Majority (81.3%) felt that home HbA1c testing was beneficial with most commonly reported benefit of not having a clinic visit. A key finding was the average of diabetes-related visits being significantly lower post-intervention with comparable HbA1c values pre- and post-intervention. The most commonly reported challenge was using Bluetooth to transmit the reading (43.7%), followed by having too many steps to remember (28.1%). While participants reported being overall satisfied with the intervention, only 22% were willing to pay for it.

conclusionOur findings support home HbA1c testing by patients coupled with telemonitoring and teleconsultations. Following are practical recommendations for the implementation scaling phase: offering PTEC HAT Programme to suitable patients who are self-motivated and have adequate digital literacy, provision of adequate educational and training support, sending reminders and exploring enabling manual submission of HbA1c readings considering Bluetooth-related challenges.

Indexed as

Diabetes Mellitus, Type 2Glycated HemoglobinAdultAgedFeasibility StudiesFemaleHome Care ServicesHumansMaleMiddle AgedPatient SatisfactionPilot ProjectsPoint-of-Care TestingPrimary Health CareSelf-TestingSingaporeGlycated Hemoglobinhemoglobin A1c protein, humanDiabetesHbA1c testingPoint-Of-Care testingTele-monitoring

Identifiers

PMID38654201
PMCPMC11040893
OpenAlexW4395037793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.